Q: To follow your answer to Elaine today, which one you prefer: DHX, DHX-b, DHX-A.
Thank you.
Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: If I buy FSV prior to May 27,does this mean I will get 2 companies(NFS & CIG) when it splits on June 1,& what are number of shares for each new co.Reportedly,the 2 new shares will commence trading on May 27..Please enlighten me.Please advise when is the time to buy-on May 27 or May 29 or after Jun 1.Thanks for your usual great views & services
Q: I would like to buy DHX.b but the recent increase in price makes me wonder if it is getting too expensive. Your thoughts?
Q: Good Morning Peter, Ryan, and Team,
I have been slowly accumulating shares of Sylogist Ltd. over the last couple of quarters while the price has been weak. Could I please get your opinion of their Q2 2015 results and their outlook ??? Thank you and have a great day. DL
I have been slowly accumulating shares of Sylogist Ltd. over the last couple of quarters while the price has been weak. Could I please get your opinion of their Q2 2015 results and their outlook ??? Thank you and have a great day. DL
Q: Hi, Could you please comment on Sylogist earnings, released this morning? Looks like another quarter of solid growth in revenue and Profit ( before taxes). What are your thoughts on dividend increase and CEO comments on NCIB and acquisition plans in Canada and US? Thank you
Q: I believe you've referred to DHX as being a cyclical stock. I'd appreciate if you could explain why.... I'm trying to understand this term and the application.
Thanks in advance!
Thanks in advance!
Q: Do you have any insight to the big price move? It seems to have shot up today on "no news".
Q: Peter and Team,
My stock portfolio largely resembles the 5i balanced equity portfolio. I recently trimmed Stella Jones from 6% of the portfolio down to 5% to keep its weighting in line. I have been building my position in BIN and currently have 3.2% of the portfolio in it. Is BIN a good spot to invest my profits from SJ today?
My stock portfolio largely resembles the 5i balanced equity portfolio. I recently trimmed Stella Jones from 6% of the portfolio down to 5% to keep its weighting in line. I have been building my position in BIN and currently have 3.2% of the portfolio in it. Is BIN a good spot to invest my profits from SJ today?
Q: Apparently the judge on the Ericsson case through out the two contender,this is the stronger case for Win as result this stock keep going south unfortunately i allocate 5% of my income portfolio on this stock, should i lighten up and reallocate some .
Q: Good morning .. I was surprised to hear from a BNN guest that ACQ has a very high level of debt. Is this so?
Q: There was a 5.5% drop for CPX today with no news for the stock and no downgrades... Any idea what could have caused it? The stock seems to be on decline and it is 9% down YTD and almost 20% lower that it was at its highest point in Aug. 2014. I have about 2% position in CPX, do you suggest to take any actions or just patiently wait for recovery?
Q: Can't believe no one asked about this today. What do you make of the Amaya support for the bwin bid?
thanks,
Rob
thanks,
Rob
Q: Is CGX buyable at the current price, or should I wait for a pullback? Didn't have the funds to purchase on the recent pullback and missed it!
Thanks in advance
Thanks in advance
Q: Could you tell me when ESL will report their latest earnings?
Thank you. Don.
Thank you. Don.
Q: Hi,
I own CSE at $4.05 Do you guys think it's a buy sell or hold at today's level? I don't mind doubling down if you think they can sustain the dividend and the price can gradually come back. Or, do you think the downside risk of losing the Bristol water appeal could drag the share price lower if it's not already baked in?
Thank you
I own CSE at $4.05 Do you guys think it's a buy sell or hold at today's level? I don't mind doubling down if you think they can sustain the dividend and the price can gradually come back. Or, do you think the downside risk of losing the Bristol water appeal could drag the share price lower if it's not already baked in?
Thank you
Q: Could you comment on GH Q1 please? Is the divvy covered and would you start to top up a position or wait for a bit of bounce up. Technically it looks to be establishing a floor.
Thank You Ron
Thank You Ron
Q: Data from Globe Investor Gold gives TCN P/E(ttm) as 9.10. Forward P/E is predicted to be 22.79. This could imply that the stock price could more than double, or the earnings could fall by more than half, or anything in between.
What would be your best guess for the stock price of TCN a year from now.
Thanks for your clairvoyance !!
Glen
What would be your best guess for the stock price of TCN a year from now.
Thanks for your clairvoyance !!
Glen
Q: Hi, After the recent run up to $43, subsequent to Fundtech acquisition news and upward revision of price targets by most analysts, stock seems to be taking a breather, lately. Do you think anything has changed in its outlook? I am considering to add to my position in @$40-$41 range for growth/income over long term and would appreciate your thoughts. Thanks
Q: How much are the rights worth to either sell or buy more?
Is their value diminishing with time
Thankyou
Is their value diminishing with time
Thankyou
Q: Regarding 5i's May 8 assessment of Trimac's Q1 earnings, the company at its website http://www.trimac.com/page/InvestorRelations
has very different and much worse numbers which would explain the stock's 12% tumble since pre-release.
Would you like to restate your outlook for this stock based on the different numbers and would it still be a top pick as it was on BNN last October? Thanks, J.
has very different and much worse numbers which would explain the stock's 12% tumble since pre-release.
Would you like to restate your outlook for this stock based on the different numbers and would it still be a top pick as it was on BNN last October? Thanks, J.